BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14168518)

  • 1. THE USE OF METYRAPONE AS AN ALDOSTERONE ANTAGONIST.
    DAVIES MS; HETZEL BS; KEARNEY GM; WILSON GM
    Clin Pharmacol Ther; 1964; 5():296-300. PubMed ID: 14168518
    [No Abstract]   [Full Text] [Related]  

  • 2. MECHANISM OF THE DIURETIC ACTION OF D-AMPHETAMINE.
    SPELLER PJ; STREETEN DH
    Metabolism; 1964 May; 13():453-65. PubMed ID: 14169224
    [No Abstract]   [Full Text] [Related]  

  • 3. [METOPIRONE IN LIVER CIRRHOSIS: DIURETIC AND ELECTROLYTIC CHANGES].
    BONINI A; TENZE L
    Fegato; 1963 Dec; 18():471-6. PubMed ID: 14117145
    [No Abstract]   [Full Text] [Related]  

  • 4. [NATRIURETIC DRUGS].
    ARMASCRUZ R; GOMEZ R; MARDONES J; PLAZADELOSREYES M
    Rev Med Chil; 1963 Nov; 91():793-810. PubMed ID: 14125670
    [No Abstract]   [Full Text] [Related]  

  • 5. METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES.
    GINSBERG DJ; SAAD A; GABUZDA GJ
    N Engl J Med; 1964 Dec; 271():1229-35. PubMed ID: 14234267
    [No Abstract]   [Full Text] [Related]  

  • 6. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES IN MYASTHENIA GRAVIS. PITUITARY-ADRENAL FUNCTION.
    KLEIN JJ; OSSERMAN KE
    N Engl J Med; 1964 Jul; 271():177-81. PubMed ID: 14158355
    [No Abstract]   [Full Text] [Related]  

  • 8. IDIOPATHIC EDEMA ND HYPERALDOSTERONURIA: POSTURAL VENOUS PLASMA POOLING.
    FISHER DA; MORRIS MD
    Pediatrics; 1965 Mar; 35():413-24. PubMed ID: 14258654
    [No Abstract]   [Full Text] [Related]  

  • 9. ANGIOTENSIN INFUSIONS IN AN ADRENALECTOMIZED PATIENT.
    BIRON P
    Rev Can Biol; 1964 Dec; 23():473-5. PubMed ID: 14257894
    [No Abstract]   [Full Text] [Related]  

  • 10. THE MANAGEMENT OF ASCITES.
    SMITH AN; MCMANUS J
    Rev Surg; 1964; 21():1-16. PubMed ID: 14106700
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDY OF ADRENAL FUNCTION AND HYDROMINERAL METABOLISM IN AN EDEMATOUS PATIENT TREATED WITH SU-4885].
    MARGOULIES M
    Rev Med Liege; 1963 Sep; 18():580-3. PubMed ID: 14091661
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE ACTION OF PROLONGED CORTICOTHERAPY ON CORTICOTROPIC AND ADRENAL FUNCTION (STUDIED BY MEANS OF THE METOPIRONE TEST)].
    LOUYOT P; GAUCHER A; BENOIT P
    Ann Med Nancy; 1964 Nov; 3():1252-65. PubMed ID: 14243726
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE SUBJECT OF DIURESIS WITH METOPIRONE (SU-4885)].
    CEREDA UG; FRANZINI P
    Minerva Med; 1964 Jul; 55():2335-8. PubMed ID: 14181820
    [No Abstract]   [Full Text] [Related]  

  • 14. PHARMACODYNAMIC EFFECTS OF A NEW DIURETIC DRUG, ETHACRYNIC ACID.
    BREST AN; ONESTI G; SELLER R; RAMIREZ O; HEIDER C; MOYER JH
    Am J Cardiol; 1965 Jul; 16():99-105. PubMed ID: 14314210
    [No Abstract]   [Full Text] [Related]  

  • 15. USE OF METHOPYRAPONE (SU-4885) IN THE STUDY OF PITUITARY-ADRENAL RESPONSE IN PATIENTS UNDER CORTICOSTEROID TREATMENT.
    JANCHES M; GOLDBERG V; SEGALL ; JAIMOVICH L; CATOGGIO P; DELABALZE FA
    J Clin Endocrinol Metab; 1965 Apr; 25():534-9. PubMed ID: 14277389
    [No Abstract]   [Full Text] [Related]  

  • 16. THE NATRIURETIC AND ALDOSTERONE-SUPPRESSIVE ACTION OF HEPARIN AND SOME RELATED POLYSULFATED POLYSACCHARIDES.
    SCHLATMANN RJ; JANSEN AP; PRENEN H; VAN DER KORST JK; MAJOOR CL
    J Clin Endocrinol Metab; 1964 Jan; 24():35-47. PubMed ID: 14112242
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF A SALT LOAD AND ALDOSTERONE ON THE ACID-BASE-EQUILIBRIUM AND ON THE ELECTROLYTES IN BLOOD AND URINE OF NORMAL SUBJECTS FOLLOWING CHEMICAL BLOCKADE OF THE ADRENAL CORTEX.
    MARTINI O; VOIGT KD; TAMM J; DOELLE W
    Acta Endocrinol (Copenh); 1964 Dec; 47():619-32. PubMed ID: 14253886
    [No Abstract]   [Full Text] [Related]  

  • 18. MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION.
    BLEDSOE T; ISLAND DP; RIONDEL AM; LIDDLE GW
    J Clin Endocrinol Metab; 1964 Aug; 24():740-6. PubMed ID: 14202753
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INHIBITION OF DIMETHYLBENZANTHRACENE-INDUCED ADRENAL CORTICAL NECROSIS.
    WONG TW; WARNER NE
    Endocrinology; 1964 Feb; 74():284-9. PubMed ID: 14122536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.